Previous 10 | Next 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips After a volatile 2020, the U.S. economy is ready for a massive turnaround this year. The S&P 500 index dropped more than 30% in just 30 days in the first quarter of 2020. However, this year the benchmark gauge has sta...
Mesa Laboratories (MLAB): FQ3 GAAP EPS of -$0.89 misses by $1.21.Revenue of $34.17M (+7.9% Y/Y) beats by $1.34M.Press Release For further details see: Mesa Laboratories EPS misses by $1.21, beats on revenue
LAKEWOOD, Colo., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the third quarter (“3Q21”) and nine months ended December 31, 2020. Financial highlights for the quarter and nine months ended December 31, 2020 as comp...
LAKEWOOD, Colo., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa Labs” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. Th...
Mesa Laboratories (MLAB): Q2 GAAP EPS of $0.51 beats by $0.45.Revenue of $31.86M (+24.7% Y/Y) beats by $1.58M.Press Release For further details see: Mesa Laboratories EPS beats by $0.45, beats on revenue
LAKEWOOD, Colo., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the second quarter (“2Q21”) and six months ended September 30, 2020. Financial highlights for the quarter and six months ended September 30, 2020 as com...
Mesa Laboratories (NASDAQ: MLAB ) : Q1 Non-GAAP EPS of $1.67 misses by $0.11 ; GAAP EPS of $0.22 misses by $0.17 . More news on: Mesa Laboratories, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
LAKEWOOD, Colo., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the first quarter (“1Q21”). Financial highlights for the quarter ended June 30, 2020 as compared to last year: Revenues increased 14% Operating inc...
Source: Mesa Laboratories, Inc. – June 16, 2020 11:30 AM ET Lakewood, Colo., June 16, 2020 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB) (“Mesa Labs”) today announced that the underwriters for its previously announced public offering of c...
Mesa Laboratories (NASDAQ: MLAB ) has priced its public offering of 600,000 common shares at $225.00/share for gross proceeds of ~$135M. More news on: Mesa Laboratories, Inc., Healthcare stocks news, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Mesa Laboratories Inc. Company Name:
MLAB Stock Symbol:
NASDAQ Market:
Mesa Laboratories Inc. Website:
2024-07-03 04:14:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
LAKEWOOD, Colo., June 05, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its fourth fiscal quarter (“4Q24”) and fiscal year ( ...